CIK 0000898437 · Accelerated filer
Anika Therapeutics, Inc.
Sign in to watch- Ticker
- ANIK
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043145961
- Phone
- (781) 457-9000
- Business address
- 32 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ANIKA THERAPEUTICS INC, ANIKA RESEARCH INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-10 | LAND RAYMOND J Director | Sale | −3,446 | $36.77 | $127K | 9,953 |
| 2020-10-30 | Finnerty Thomas EVP Human Resources | Shares withheld for taxes | −666 | $32.62 | $22K | 7,581 |
| 2020-09-03 | Richard Stephen Director | Grant or award | +9,310 | 9,310 | ||
| 2020-09-03 | HENNEMAN JOHN B III Director | Grant or award | +9,310 | 9,310 | ||
| 2020-08-10 | Levitz Michael L EVP, CFO, Treasurer | Grant or award · Restricted Stock Unit | +11,577 | 11,577 | ||
| 2020-08-10 | Levitz Michael L EVP, CFO, Treasurer | Grant or award · Stock Option (Right to Buy) | +57,145 | 57,145 | ||
| 2020-07-09 | Loerop James EVP Business Development | Sale | −1,244 | $35.15 | $44K | 1,756 |
| 2020-07-08 | Loerop James EVP Business Development | Grant or award | +3,000 | 3,000 | ||
| 2020-04-26 | Blanchard Cheryl R President, CEO, Director | Option exercise | +4,231 | 11,697 | ||
| 2020-04-26 | Blanchard Cheryl R President, CEO, Director | Shares withheld for taxes | −1,794 | $33.40 | $60K | 9,903 |
| 2020-04-26 | Blanchard Cheryl R President, CEO, Director | Grant or award · Restricted Stock Unit | +73,726 | 73,726 | ||
| 2020-04-26 | Blanchard Cheryl R President, CEO, Director | Grant or award · Stock Option (Right to Buy) | +104,638 | 104,638 | ||
| 2020-03-04 | Colleran David EVP, General Counsel, Corp Sec | Grant or award · Restricted Stock Unit | +7,500 | 7,500 | ||
| 2020-03-04 | Colleran David EVP, General Counsel, Corp Sec | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2020-02-26 | LAND RAYMOND J Director | Sale | −2,700 | $42.68 | $115K | 13,399 |
| 2020-02-26 | Finnerty Thomas Chief Human Resources Officer | Grant or award | +3,000 | 9,128 | ||
| 2020-02-26 | Finnerty Thomas Chief Human Resources Officer | Shares withheld for taxes | −881 | $42.25 | $37K | 8,247 |
| 2020-02-26 | Cheung Sylvia Chief Financial Officer | Grant or award | +3,000 | 50,162 | ||
| 2020-02-26 | Cheung Sylvia Chief Financial Officer | Shares withheld for taxes | −881 | $42.25 | $37K | 49,281 |
| 2020-02-25 | LAND RAYMOND J Director | Grant or award | +4,107 | 16,099 |
Page 15 of 29 · 580 trades